Cartilage Hair Hypoplasia (CHH) is a rare genetic disorder that affects the development of the bones, skin, and immune system. It is caused by a mutation in the RMRP gene, which is responsible for producing a protein that helps regulate cell growth and development. People with CHH have a wide range of health complications, including skeletal abnormalities, skin problems, and immunodeficiency. In this article, we will explore the link between CHH and health complications, as well as the diagnosis and treatments available for those affected by the disorder.
Cartilage Hair Hypoplasia (CHH) is a rare genetic disorder caused by a mutation in the RMRP gene. This mutation prevents the production of a protein that helps regulate cell growth and development. As a result, people with CHH have abnormal development of the bones, skin, and immune system. The disorder is usually diagnosed in infancy and can cause a wide range of health complications.
People with CHH have a variety of signs and symptoms, including skeletal abnormalities, skin problems, and immunodeficiency. Skeletal abnormalities can include short stature, curved spine, and joint deformities. Skin problems can include dry, scaly skin, and hair loss. Immunodeficiency can lead to recurrent infections, including ear infections, sinus infections, and pneumonia.
CHH is usually diagnosed in infancy. Diagnosis is based on physical examination, family history, and genetic testing. Physical examination can reveal skeletal abnormalities, skin problems, and immunodeficiency. Family history can help identify if there is a history of CHH in the family. Genetic testing can confirm the diagnosis of CHH.
Treatment for CHH is aimed at managing the symptoms of the disorder. This can include physical therapy to help with physical deformities, medications to help with skin problems, and antibiotics to help with recurrent infections. In some cases, surgery may be necessary to correct skeletal deformities.
People with CHH are at risk for a variety of health complications, including skeletal abnormalities, skin problems, and immunodeficiency. Skeletal abnormalities can include short stature, curved spine, and joint deformities. Skin problems can include dry, scaly skin, and hair loss. Immunodeficiency can lead to recurrent infections, including ear infections, sinus infections, and pneumonia.
CHH is a genetic disorder, so the risk of developing the disorder is higher if there is a family history of the disorder. It is estimated that 1 in every 25,000 people is affected by CHH.
Since CHH is a genetic disorder, there is no way to prevent the disorder. However, early diagnosis and treatment can help manage the symptoms and reduce the risk of health complications.
Cartilage Hair Hypoplasia (CHH) is a rare genetic disorder that affects the development of the bones, skin, and immune system. People with CHH have a wide range of health complications, including skeletal abnormalities, skin problems, and immunodeficiency. Early diagnosis and treatment can help manage the symptoms and reduce the risk of health complications.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation